Eshelman Ventures, LLC

This profile gathers the share dealings of Eshelman Ventures, LLC across 3 companies, led by Liquidia Technologies Inc, Liquidia Corp and G1 Therapeutics, Inc. Over a trading history stretching from 22 May 2017 to 22 December 2020, the count stands at 23 filings.

In open-market terms, that means 8 purchases worth €18.2M on one side and 13 sales worth €2.7M on the other. Taken together, the purchases exceed the sales by €15.4M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Since January 2020: 7 purchases and 13 sales on the market.

In size, the median ticket on the buying side is €179k. On 1 out of 8 purchases, another insider of the same company was buying within the same 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

The latest filing, published on 28 December 2020, reports an open-market sale of €20k in Liquidia Corp. The clock since the last published purchase (2 July 2020) now reads 2,302 days. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.